Search results
Showing 8146 to 8160 of 8980 results
Moxetumomab pasudotox for treating hairy-cell leukaemia [ID1142]
Discontinued Reference number: GID-TA10923
Nintedanib for treating interstitial lung disease caused by systemic sclerosis [ID1420]
Discontinued Reference number: GID-TA10427
Etirinotecan pegol for treating breast cancer with brain metastases [ID881]
Discontinued Reference number: GID-TA10066
Bevacizumab for the treatment of recurrent glioblastoma multiforme [ID80]
Discontinued Reference number: GID-TAG413
Discontinued Reference number: GID-TAG493
Ublituximab with ibrutinib for previously treated chronic lymphocytic leukaemia [ID1476]
Discontinued Reference number: GID-TA10447
Discontinued Reference number: GID-TA10397
Pexidartinib for treating symptomatic tenosynovial giant cell tumour [ID1682]
Discontinued Reference number: GID-TA10609
Breast cancer (HER2-negative, BRCA-mutation, unresectable) - niraparib [ID1084]
Discontinued Reference number: GID-TA11178
Ridaforolimus for the maintenance treatment of metastatic soft tissue or bone sarcoma [ID415]
Discontinued Reference number: GID-TAG431
Discontinued Reference number: GID-TAG418
Everolimus for the treatment of prophylaxis of organ rejection in cardiac transplantation [ID114]
Discontinued Reference number: GID-TAG232
Discontinued Reference number: GID-TAG394
Discontinued Reference number: GID-TAG432
Discontinued Reference number: GID-TAG427